US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

AMGN

Amgen (AMGN)

Amgen Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AMGN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 21	PR Newswire (US)	FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE	NASDAQ:AMGN	Amgen Inc
2024/06/13	06 : 23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AMGN	Amgen Inc
2024/06/12	22 : 00	PR Newswire (US)	AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024	NASDAQ:AMGN	Amgen Inc
2024/06/06	05 : 00	PR Newswire (US)	AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE	NASDAQ:AMGN	Amgen Inc
2024/06/05	22 : 00	PR Newswire (US)	AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/05	08 : 22	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/06/04	06 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMGN	Amgen Inc
2024/06/04	05 : 00	PR Newswire (US)	AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE	NASDAQ:AMGN	Amgen Inc
2024/05/28	22 : 00	PR Newswire (US)	AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024	NASDAQ:AMGN	Amgen Inc
2024/05/20	06 : 15	PR Newswire (US)	NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD	NASDAQ:AMGN	Amgen Inc
2024/05/17	07 : 46	PR Newswire (US)	FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER	NASDAQ:AMGN	Amgen Inc
2024/05/16	07 : 45	PR Newswire (US)	AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024	NASDAQ:AMGN	Amgen Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc
2024/05/10	08 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMGN	Amgen Inc

Showing the most relevant articles for your search:NASDAQ:AMGN

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

BNP Paribas (QX)

JP Morgan Chase

Financial Select Sector

Bank of America

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約